ARCTIC: Liquid biomarkers in the prospective ARSI Resistance Clinical Trials - sIRB

Study Details

Full Title

Clinical Validation of a Circulating Tumor Cell AR Therapy Resistance Assay in Men with Metastatic Castration Resistant Prostate Cancer (ARCTIC) - sIRB

Principal Investigator

Andrew
Armstrong

Protocol Number

PRO00111532

NCT ID

NCT06141993

Phase

N/A

Enrollment Status

Open to Enrollment